(Q37847072)

24 August 2017

1 reference

title

Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians (English)

1 reference

24 August 2017

author name string

Judith Frances Margolin

series ordinal

1

1 reference

24 August 2017

language of work or name

1 reference

25 February 2011

1 reference

European Journal of Pediatrics

24 August 2017

published in

1 reference

24 August 2017

volume

170

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

419-425

1 reference

Pediatric oncology in India: Past, present and future

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Minimal residual disease in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Therapy of low-risk subsets of childhood acute lymphoblastic leukemia: when do we say enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Shared management of children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

New insight into the molecular mechanisms of MLL-associated leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Challenges after curative treatment for childhood cancer and long-term follow up of survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

High hyperdiploid childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Biology and treatment of acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Malignancy in children with trisomy 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Treatment of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Assessing the health care needs of adolescent and young adult cancer patients and survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Acute leukemias in children with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-011-1424-7

Inactivation of LEF1 in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

12 December 2020

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study

1 reference

12 December 2020

Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study

1 reference

12 December 2020

Acute myeloid leukemia

1 reference

12 December 2020

Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia

1 reference

12 December 2020

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

12 December 2020

Immunisation practices of paediatric oncology and shared care oncology consultants: a United Kingdom survey

1 reference

12 December 2020

Identification of a gene expression signature associated with pediatric AML prognosis

1 reference

12 December 2020

Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia

1 reference

12 December 2020

Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)

1 reference

12 December 2020

Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia

1 reference

12 December 2020

New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases

1 reference

12 December 2020

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

12 December 2020

Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

10.1007/S00431-011-1424-7

Identifiers

DOI

1 reference

24 August 2017

1 reference